Sulggi Lee
Infectious Disease · San Francisco, CANPI 1558541383
Payments from drug & device makers
What this record shows
That places this record below the midpoint for infectious disease clinicians in CA, where the typical reported total is $297.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$1,216,541in research payments, 2019–2025
Across 12 payments — averaging $101,378 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1.1M
- Viiv Healthcare Company$145K
How this compares
$0 in reported general payments places this provider in the 10th percentile of 856 infectious disease providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TriumeqAbacavir/Dolutegravir/Lamivudi | 32 | $117,264 |
| TivicayDolutegravir Sodium | 27 | $59,129 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 11 | $49,929 |
| DescovyEmtricitabine/Tenofov Alafenam | 18 | $42,247 |
| Darunavir | 20 | $17,854 |
| Ritonavir | 14 | $2,005 |
| Efavirenz | 14 | $1,551 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $1,517 |
| Ventolin HfaAlbuterol Sulfate | 17 | $885 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $540 |
| Finasteride | 19 | $183 |
| Atorvastatin Calcium | 31 | $144 |
| Lisinopril | 18 | $75 |
| Amlodipine Besylate | 13 | $73 |
| Metformin Hcl | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in San Francisco
- Shawn HasslerSan Francisco$433K
- Abhijit LimayeSan Francisco$152K
- Joel PalefskySan Francisco$68K
- Monica GandhiSan Francisco$60K
- Claire PomeroySacramento$2.6M
- Javeed SiddiquiRoseville$1.5M
- George SakoulasSan Diego$902K
- Arthur JengSylmar$766K
- James McKinnellTorrance$762K
- Jay GladsteinLos Angeles$657K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.